DC Chemicals

All products / DC22191

PBT434
CAT. NO. DC22191

PBT434

Pack sizes and prices

Pack sizePrice
100 mg$650 USDRequest a quote →
250 mg$1,100 USDRequest a quote →
1 g$2,200 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

PBT434 is a novel quinazolinone compound with effect of lowering cellular iron levels, prevents iron mediated neurodegeneration and α-synuclein toxicity in multiple models of Parkinson disease; inhibits iron-mediated redox activity and iron-mediated aggregation of α-synuclein, a protein that aggregates in the neuropathology; prevents loss of substantia nigra pars compacta neurons (SNpc), lowers nigral α-synuclein accumulation, and rescues motor performance in mice model of PD.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC22191
Product namePBT434
CAS1232841-78-9
Molecular formulaC12H14BrCl2N3O2
Molecular weight383.067
Purity>98%
SMILESN1C2=C(C(Cl)=CC(Cl)=C2O)C(=O)N(C)C=1CNCC.[HH0]Br

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — PBT434 (DC22191)

Related research products